A practical development route for skincare brands preparing products for the EU, Great Britain and Northern Ireland markets.
INTE supports formula development, factory documentation, testing coordination, packaging information and production readiness. The appointed Responsible Person and qualified safety assessor remain responsible for the final regulatory decision.
EU and UK skincare projects involve more than formula development and manufacturing. The formula, ingredients, packaging, label information, testing plan and regulatory route need to be aligned before the product is released for commercial production.
INTE adiuvat marcas ad ordinandum informationem ex parte fabricae et ex parte producti, quae ad examen regulatorium requiritur, dum responsabilitates fabricantis, Personae Responsabilis et assessoris securitatis clare separantur.
Traducere brevem descriptionem producti, exemplar comparationis aut conceptum producti in formulam et directionem imballagii factibilem.
Parare informationem de fabricatione, ingredientibus, imballagio et experimentis pro partibus regulatoriis nominatis.
Coordinationem confirmationis formulae finalis, inspectionis artificii, status experimentorum et particularum productionis ante fabricationem massivam.
Projectum OEM fidele debet clarificare, quae informationes a fabrica praebentur et quae decisiones a partibus regulatoriis nominatis capiendae sunt.
INTE non agit ut Persona Responsabilis. Praebemus informationes technicas ex parte fabricae et ex parte producti, quas Persona Responsabilis nominata et peritus assessor securitatis requirunt.
Efficientissima opera non exspectant usque ad finem evolutionis ut de conformitate cogitent. Experimenta, examen ambagum et praeparatio regulativa simul cum evolutione formulae disponenda sunt.
Confirmare categoriam producti, consummatorem destinatum, affirmationes intentas, mercatum destinatum, texturam, ingredientia et tempus expectatum initiationis.
Examinare novum conceptum, formulam iam existentem aut exemplar comparationis et confirmare viam evolutionis aptam.
Examinare formatum implendi, ambages primarias, considerationes de compatibilitate, ornamenta et informationes necessarias in titulis.
Plan stability, microbiological, packaging compatibility and claims-supporting testing where relevant.
Confirm the EU or GB Responsible Person and the address that will be used on the product packaging.
Review mandatory product information and approve print-ready artwork only after RP details are confirmed.
Provide product information for CPSR, PIF, CPNP or SCPN preparation by the appointed regulatory parties.
Confirm formula, packaging, testing status, artwork and production details before commercial manufacturing.
Before a skincare product moves into production, the factory-side information must be complete enough for the Responsible Person and safety assessor to review.
Praeparatio regulatoria et experimenta producti non debent ut duo prorsus separata momenta tractari. Planum experimentorum considerandum est dum formula et impacchagium definitur.
Ubi idoneum est, experimenta peragenda sunt utendo formula finali et configuratione finali imballagii. Mutationes post experimenta ulteriorem recensionem aut repetitionem experimentorum requirere possunt.
Projectum practicum documenta technica a fabricante praebita a documentis specificis ad mercatum, quae a Persona Responsabili et assessore securitatis definitiva sunt, separat.
One of the most common sources of avoidable packaging rework is approving the label before the Responsible Person has been confirmed.
Decide whether the product is intended for the EU, Great Britain, Northern Ireland or multiple markets.
Confirm the legal name and address of the appointed Responsible Person before approving final artwork.
Review mandatory product information and only then release the artwork for printing and production.
EU, Great Britain and Northern Ireland should not be treated as one single regulatory route. The Responsible Person, notification process and safety review should be confirmed according to the actual destination market.
| MARKET | Main Notification Route | Responsible Person and Review |
|---|---|---|
| EU Member States | CPNP | An EU-established Responsible Person handles the applicable EU notification and regulatory responsibilities. |
| Magnae Britanniae | SCPN | A UK-established Responsible Person is required. The product requires a GB-specific regulatory review. |
| Northern Ireland | Separate route assessment | The applicable EU or NI route should be confirmed separately according to the product and market arrangement. |
An EU CPSR should not be assumed to automatically cover Great Britain. The product should undergo a GB-specific review, adaptation or re-signing where required by the qualified safety assessor and UK Responsible Person.
INTE does not act as the Responsible Person. We provide the product, manufacturing and technical information required by the appointed regulatory parties.
For products placed on the EU market, the EU Responsible Person is responsible for submitting the required product information to the Cosmetic Products Notification Portal, or CPNP, before the product is placed on the market.
Nomen producti, categoria, notae personae responsabilis et mercatus in quo productum adhiberi poterit.
Notae formulae applicabilis et, ubi opus est, formula quadri pro cura medica urgenti.
Notae quae ad formulam pertinent inter brandum, fabricantem et partes regulatorias tractantur secundum pacta de confidencialitate.
Formula quadri non idem est ac publicatio formulae commercialis plenae. INTE potest parare et praebere notitias producti pertinentes ad examen regulatorium, dum persona responsabilis UE adhuc responsabilis manet pro notificatione finali CPNP.
Ad introitum in mercatum UE, complentia experimentorum in animalibus consideranda est tam in producto cosmeticum finito quam in ingredientibus.
INTE can coordinate available supplier declarations and traceability documents for review. The final interpretation and acceptance of the evidence must be made by the Responsible Person and qualified safety assessor.
Before approving mass production, we recommend confirming the following items with your project team and regulatory partners.
The EU or GB Responsible Person has been appointed and the legal address is confirmed.
The formula, ingredients, fragrance and preservative system have been finalized.
The primary packaging and compatibility requirements have been reviewed.
Stability, microbiological, compatibility and claims-supporting testing has been planned where relevant.
The EU, GB or NI route has been clearly defined and the required regulatory parties are aligned.
Informationes obligatoriae de etiquetta iam recensitae sunt antequam ars graphica ad impressionem emittitur.
Non. INTE non agit ut Persona Responsabilis. Nos informationes technicas ex parte fabricae et ex parte producti praebemus Personae Responsabili nominatae et assessori securitatis idoneo.
Rapportus de Securitate Compositionis (CPSR) pro Unione Europaea non debet automato supponi valere pro Magna Britannia. Projectum recensendum est ad normas Magnae Britanniae et, ubi opus sit, adaptandum vel rursus signandum a assessore securitatis idoneo et a Persona Responsabili Regni Uniti.
Persona Responsabilis optime confirmatur antequam ars graphica definitiva imballagii approbatur. Nomen et adresa Personae Responsabilis fortasse in imballagio producti apponendae sunt.
A frame formulation is formula information used for the EU notification process and intended to support prompt and appropriate medical treatment in the event of difficulties. It is not the same as publishing the full commercial formula.
Testing should be planned during formula and packaging development. Where relevant, final testing should use the final formula and final packaging configuration.
INTE can provide relevant factory-side GMP / ISO 22716-related documentation and manufacturing information for regulatory review, subject to the project scope and the applicable certified manufacturing entity.
INTE can coordinate available supplier declarations, traceability documents and factory-side information for review. Final interpretation and acceptance remain with the Responsible Person and qualified safety assessor.
Share your product concept, target market, preferred formula or benchmark, packaging direction, expected quantity and target launch date. Our team will help you identify the appropriate development, testing and manufacturing route.
Request an EU/GB Readiness ReviewCopyright © 2025 by Inte Cosmetics (shenzhen) Co., Ltd.